Lung Cancer: How Well We Have Fared? | Zendy

Pradeep S. Patil | Zendy; Hitendra S. Mahajan | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Lung Cancer: How Well We Have Fared?

Author(s) -

Pradeep S. Patil,

Hitendra S. Mahajan

Publication year - 2022

Publication title -

indo global journal of pharmaceutical sciences

Language(s) - English

Resource type - Journals

ISSN - 2249-1023

DOI - 10.35652/igjps.2022.12007

Subject(s) - medicine , lung cancer , intensive care medicine , death toll , disease , cancer , treatment of lung cancer , cause of death , oncology , environmental health

Lung Cancer has been one of the most common causes of death worldwide. With the death toll increasing in millions every year globally it has become a global scourge. With poor prognosis and disappointing 5 years survival rate post diagnosis, treatment for this disease has been ambiguous. Various advances in treatment are being made but till date the 5 years survival for major patients remains a dream. This review encompasses different treatment options that are available, problems associated with treatment and future perspective for the treatment of lung cancer. ©2022iGlobal Research and PublishingFoundation. All rights reserved.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research